CytoDyn to Present Pivotal Data at ASM Microbe 2019 Demonstrating Efficacy and Safety of Leronlimab (PRO 140) in HIV Patients with Multiple ARV Class Resistance
Stock Information for Cytodyn Inc
Loading
Please wait while we load your information from QuoteMedia.